Apogee Therapeutics (APGE) Cash & Current Investments (2022 - 2026)
Apogee Therapeutics (APGE) reported Cash & Current Investments of $866.4 million for Q2 2026, up 127.3% from $381.23 million a year earlier and up 42.5% from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Cash & Current Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Apogee Therapeutics posted Cash & Current Investments of $598.64 million, up 58.0% from FY2024.
- Cash & Current Investments has increased for three consecutive years, with a three-year compound annual growth rate of 58.0% (FY2022 to FY2025).
- By year, Cash & Current Investments came in at $378.86 million in FY2024 (+36.7%), $277.14 million in FY2023 (+82.5%) and $151.89 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Cash & Current Investments in data going back to Q2 2022.
- Year over year, Cash & Current Investments has now increased in each of the last nine quarters, with growth averaging 46.8% over the last eight quarters.
- The year-over-year growth in Cash & Current Investments has ranged between 3.0% (Q3 2025) and 194.9% (Q2 2024) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $608.1 million (Q1 2026), $598.64 million (Q4 2025) and $419.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | 866.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 866.40 Mn |
| Mar 31, 2026 | 608.10 Mn |
| Dec 31, 2025 | 598.64 Mn |
| Sep 30, 2025 | 419.40 Mn |
| Jun 30, 2025 | 381.23 Mn |
| Mar 31, 2025 | 406.41 Mn |
| Dec 31, 2024 | 378.86 Mn |
| Sep 30, 2024 | 407.30 Mn |
| Jun 30, 2024 | 368.93 Mn |
| Mar 31, 2024 | 330.74 Mn |
| Dec 31, 2023 | 277.14 Mn |
| Sep 30, 2023 | 234.60 Mn |
| Jun 30, 2023 | 125.10 Mn |
| Dec 31, 2022 | 151.89 Mn |
| Jun 30, 2022 | 4.97 Mn |
API Access
Apogee Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();